Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Manipal, TPG swoop in with sweetened bid for India's Fortis

Published 15/05/2018, 05:33
Updated 15/05/2018, 05:40
© Reuters. A Fortis hospital building is pictured in Gurgaon

© Reuters. A Fortis hospital building is pictured in Gurgaon

By Aditi Shah and Alasdair Pal

NEW DELHI/LONDON (Reuters) - India's Manipal Hospital and private equity firm TPG Capital Management (TPG.UL) on Monday sweetened their bid to buy Fortis Healthcare Ltd (NS:FOHE), just days after the Fortis board said it favoured a rival offer to the dismay of many shareholders.

Fortis shares rose as much as 4.2 percent to 155 rupees on Tuesday, marking their biggest intraday percentage gain in nearly two weeks.

Fortis, late on Thursday, said it planned to accept an offer from Hero Enterprise Investment Office and Burman Family Office that would invest 18 billion rupees (196.5 million pounds), valuing Fortis at 90 billion rupees, subject to shareholder approval.

The decision drew investors' ire and sent shares in the cash-strapped hospital operator down almost 5 percent.

It is uncertain if shareholders would give their nod to the offer from Hero Enterprise Investment Office and Burman Family Office, said an analyst, who requested anonymity.

The keen interest in Fortis emerges as Indian Prime Minister Narendra Modi looks to implement a healthcare programme aimed at providing insurance cover to hundreds of millions of people in a country with a dearth of adequate medical clinics. The scheme is expected to make private hospitals, such as those run by Manipal and Fortis, accessible to millions of poor families.

Manipal said in a statement on Monday it would offer Fortis 180 rupees a share, valuing the company at 94.03 billion rupees ($1.39 billion).

The new offer is significantly better than any other offer or bid that Fortis has received to date, including the one by Hero and Burman, Manipal said in its statement, urging Fortis' board of directors to refer the offer to its shareholders.

"This is a real offer," a major shareholder in Fortis told Reuters. "This is getting in the territory of a fair bid."

"Given (Manipal) already runs a large hospital chain they are probably in the best position to ring out synergies," said the investor, adding Fortis had not yet entered into a binding bid and could change its recommendation to shareholders.

Fortis had initially agreed to a deal with the Manipal-TPG consortium, but shareholder objections and competing offers scuttled that deal.

It had also received an offer of investment from Malaysia's IHH Healthcare Bhd (KL:IHHH), peer Radiant Life Care with global private equity firm by KKR & Co (N:KKR), and a non-binding offer of investment from China's Fosun International (HK:0656).

"It's the first serious deal from Manipal that deserves full consideration," said another major shareholder in Fortis.

© Reuters. A Fortis hospital building is pictured in Gurgaon

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.